ARMP ▲ +1.4% - Armata Pharmaceuticals, Inc. $ARMP ARMP ARMP - Armata Pharmaceuticals to Present Data at ISSSI 2026 Showing Defined Genetic Diversity in AP-SA02 May Enhance Killing of Certain Staphylococcus aureus Clinical Isolates Armata Pharmaceuticals rose 1.4% today following news that the company will present data at ISSSI 2026 demonstrating that genetic diversity in its AP-SA02 candidate may improve its ability to eliminate certain clinical isolates of Staphylococcus aureus. The presentation of efficacy data for an anti-infective program appears to have bolstered investor confidence in the company's pipeline. 21-SEP-2026 07:00 AM ET